Embolization for Meningioma

ConditionMeningioma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSt. Olavs Hospital

About this trial

The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often reserved to treat relapses after surgery, and except for surgery and radiotherapy there are no other established treatment methods. Endovascular embolization may be used in selected cases as a preoperative adjunct to reduce intraoperative bleeding. There is a need for more treatment options in patients with meningioma, both in uncomplicated, asymptomatic cases and in more complex cases. The aim of this study is to assess radiological and clinical results of therapeutic endovascular embolization for meningioma

Eligibility criteria

Qualifiers

Radiological diagnose of typical intracranial meningioma (homogenous contrast enhancement or dural attachment)

Indication for treatment due to growth, symptoms or both

Tumor location suggestive of vascular supply via middle meningeal artery branches

Age 18 years or older

Disqualifiers

Informed consent not possible (e.g. language barriers, aphasia, cognitive impaired)

Previously treated for meningioma

Intraosseous growth

Tumor related brain edema

Trial design

Treatments tested in this trial

  • Endovascular embolization

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators